XML 35 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
Shares issued in connection with Merger:
       
Atrinsic 25,867 shares Common stock
  $
32,334
 
Atrinsic Series A preferred stock as converted to Series B preferred
stock, 297,468 shares
   
371,835
 
Total value of shares issued to Atrinsic on Merger
   
404,169
 
Fair value of net assets identified
   
-
 
         
Goodwill
   
404,169
 
Net value of consideration
  $
-
 
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
 
 
Carrying
 
 
Fair Value Measurement Using
 
 
 
Value
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
                                         
Derivative warrants liabilities
  $
516,870
    $
    $
    $
516,870
    $
516,870
 
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
 
 
Fair Value
Measurement
Using Level 3
Inputs
 
 
 
Total
 
Balance, December 31, 2015
  $
 
Issuance of derivative warrants liabilities
   
487,425
 
Change in fair value of derivative warrants liabilities
   
29,445
 
Balance, December 31, 2016
  $
516,870
 
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
 
 
February 12, 2016
 
 
December 31, 2016
 
Exercise price
  $
1.25
    $
1.25
 
Risk free interest rate
   
1.20
%    
1.93
%
Dividend yield
   
0.00
%    
0.00
%
Expected volatility
   
156
%    
219
%
Contractual term (in years)
   
5.0
     
4.25
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
Potentially Outstanding
Dilutive Common
Shares
 
                 
   
For the Year
Ended
December
31, 2016
   
For the Year
Ended
December
31, 2015
 
                 
Conversion Feature Shares
 
 
 
 
 
 
 
 
                 
Common shares issuable under the conversion feature of preferred shares
   
872,766
     
-
 
                 
Stock Option
   
2,484,445
     
1,707,744
 
                 
Warrant
   
3,826,658
     
3,403,367
 
                 
Total potentially outstanding dilutive common shares
   
7,183,869
     
5,051,111